瘤细胞扩散是通过调节性T细胞驱动的细胞外矩阵重塑来促进的
bioRxiv : the preprint server for biology
|November 24, 2025
概括
调节性T (Treg) 细胞改变瘤细胞外基质 (ECM),促进乳腺癌细胞迁移和转移. 这种由Treg细胞驱动的ECM重塑与较差的患者存活率相关,并涉及与瘤相关的巨细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物材料科学 生物材料科学
背景情况:
- 调节性T (Treg) 细胞抑制乳腺癌的抗瘤免疫力,通过影响巨细胞促进瘤生长.
- 瘤细胞外基质 (ECM) 对转移和瘤免疫至关重要,但免疫系统对其调节的理解尚不充分.
研究的目的:
- 研究Treg细胞如何修改瘤ECM并影响乳腺癌转移.
- 探索瘤相关巨细胞 (TAMs) 和干扰素- (IFN-γ) 在Treg细胞介导的ECM变化中的作用.
主要方法:
- 用小鼠模型 (体内,体外) 和生物工程方法来研究Treg细胞-ECM相互作用.
- 分析人类乳腺癌样本中的母体体标记及其与生存率的相关性.
- 调查IFN-γ和TAM在ECM结构和功能改变中的作用.
主要成果:
- 特雷格细胞诱导瘤ECM中的特定变化,增强瘤细胞迁移和转移.
- 取决于Treg细胞的ECM特征与人类乳腺癌患者的生存率降低有关.
- 与瘤相关的巨细胞 (TAMs) 调节这些ECM签名,TAMs中的IFN-γ信号驱动ECM修改.
结论:
- Treg细胞在促进乳腺癌通过ECM重塑转移转移方面发挥着重要的,以前未被认可的作用.
- 这项研究强调了一种新的机制,Treg细胞有助于癌症的进展.
- 研究结果表明,Treg细胞是组织修复和癌症的关键调节者,影响ECM动态.
更多相关视频
10:55Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System
Published on: January 8, 2018
11.5K
05:48Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
10.1K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Extracellular Matrix
11.8K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
11.8K
The Extracellular Matrix
88.1K
Overview
88.1K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
